ID: ALA38250
Chembl Id: CHEMBL38250
PubChem CID: 9812978
Max Phase: Preclinical
Molecular Formula: C10H25N3
Molecular Weight: 187.33
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCNCCCNCCCNCC
Standard InChI: InChI=1S/C10H25N3/c1-3-11-7-5-9-13-10-6-8-12-4-2/h11-13H,3-10H2,1-2H3
Standard InChI Key: FYMKTGYXMFIGTR-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 187.33 | Molecular Weight (Monoisotopic): 187.2048 | AlogP: 0.58 | #Rotatable Bonds: 10 |
| Polar Surface Area: 36.09 | Molecular Species: BASE | HBA: 3 | HBD: 3 |
| #RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: ┄ | CX Basic pKa: 10.66 | CX LogP: -0.09 | CX LogD: -5.56 |
| Aromatic Rings: ┄ | Heavy Atoms: 13 | QED Weighted: 0.44 | Np Likeness Score: -0.12 |
| 1. Bergeron RJ, Feng Y, Weimar WR, McManis JS, Dimova H, Porter C, Raisler B, Phanstiel O.. (1997) A comparison of structure-activity relationships between spermidine and spermine analogue antineoplastics., 40 (10): [PMID:9154970] [10.1021/jm960849j] |
Source(1):
